Author:
Molenaar R J,Pleyer C,Radivoyevitch T,Sidana S,Godley A,Advani A S,Gerds A T,Carraway H E,Kalaycio M,Nazha A,Adelstein D J,Nasr C,Angelini D,Maciejewski J P,Majhail N,Sekeres M A,Mukherjee S
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Cancer Research,Hematology
Reference36 articles.
1. La Vecchia C, Malvezzi M, Bosetti C, Garavello W, Bertuccio P, Levi F et al. Thyroid cancer mortality and incidence: a global overview. Int J Cancer 2015; 136: 2187–2195.
2. Lim H, Devesa SS, Sosa JA, Check D, Kitahara CM . Trends in thyroid cancer incidence and mortality in the United States, 1974-2013. JAMA 2017; 317: 1338–1348.
3. Surveillance, Epidemiology, and End Results (SEER) Program (Research Data (1973–2014), National Cancer Institute, DCCPS, Surveillance Research Program, Surveillance Systems Branch, released April 2017, based on the November 2016 submission). Available at: http://www.seer.cancer.gov .
4. Nixon IJ, Ganly I, Patel SG, Palmer FL, Di Lorenzo MM, Grewal RK et al. The results of selective use of radioactive iodine on survival and on recurrence in the management of papillary thyroid cancer, based on Memorial Sloan-Kettering Cancer Center risk group stratification. Thyroid 2013; 23: 683–694.
5. Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE et al. American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid 2016 2015; 26: 1–133.
Cited by
33 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献